Profile
Sam J.
Milstein currently works at Cerus Endovascular Ltd., as Chairman and Cerus Endovascular, Inc., as Chairman.
Sam J. Milstein active positions
| Companies | Position | Start |
|---|---|---|
Cerus Endovascular Ltd.
 Cerus Endovascular Ltd. Medical SpecialtiesHealth Technology Cerus Endovascular Ltd. designs and develops differentiated and proprietary interventional neuroradiology devices and delivery systems. The firm's products are used for the treatment of neurovascular diseases particularly intracranial aneurysms. The company was founded in 2011 and is headquartered in Oxford, the United Kingdom. | Chairman | - |
Cerus Endovascular, Inc.
 Cerus Endovascular, Inc. Medical SpecialtiesHealth Technology Part of Stryker Corp., Cerus Endovascular, Inc. is a company that specializes in transforming interventional neuroradiology. The company is based in Fremont, CA. The company offers innovative products such as the Contour Neurovascular System, Neqstent, and Intra-saccular Flow Diversion Cerus. The CEO of the company is Stephen Griffin. | Chairman | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Cerus Endovascular Ltd.
Cerus Endovascular Ltd. Medical SpecialtiesHealth Technology Cerus Endovascular Ltd. designs and develops differentiated and proprietary interventional neuroradiology devices and delivery systems. The firm's products are used for the treatment of neurovascular diseases particularly intracranial aneurysms. The company was founded in 2011 and is headquartered in Oxford, the United Kingdom. | Health Technology |
Cerus Endovascular, Inc.
Cerus Endovascular, Inc. Medical SpecialtiesHealth Technology Part of Stryker Corp., Cerus Endovascular, Inc. is a company that specializes in transforming interventional neuroradiology. The company is based in Fremont, CA. The company offers innovative products such as the Contour Neurovascular System, Neqstent, and Intra-saccular Flow Diversion Cerus. The CEO of the company is Stephen Griffin. | Health Technology |
- Stock Market
- Insiders
- Sam J. Milstein
